These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 19695416)

  • 21. Plasminogen activation and thrombolysis for ischemic stroke.
    Medcalf RL; Davis SM
    Int J Stroke; 2012 Jul; 7(5):419-25. PubMed ID: 22463085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of tissue plasminogen activator to treat acute ischemic stroke.
    Alexandrov AW
    Crit Care Nurse; 2010 Oct; 30(5):77-8. PubMed ID: 20889516
    [No Abstract]   [Full Text] [Related]  

  • 23. Further randomized controlled trials of tissue plasminogen activator within 3 hours are required.
    Lindley RI
    Stroke; 2001 Nov; 32(11):2708-9. PubMed ID: 11692040
    [No Abstract]   [Full Text] [Related]  

  • 24. Evidence and doubt in the translation of research into care.
    Lancet; 2014 Aug; 384(9944):638. PubMed ID: 25152260
    [No Abstract]   [Full Text] [Related]  

  • 25. [Thrombolytic therapy in acute ischemic stroke: present and future].
    Mori E
    No Shinkei Geka; 2003 Mar; 31(3):249-60. PubMed ID: 12684978
    [No Abstract]   [Full Text] [Related]  

  • 26. Symptomatic ICH and outcomes in patients after IV tPA: a business of risk or risky business?
    Southerland AM; Malik S; Johnston KC
    Neurology; 2011 Jul; 77(4):315-6. PubMed ID: 21715703
    [No Abstract]   [Full Text] [Related]  

  • 27. Thrombolysis for acute stroke: the incontrovertible, the controvertible, and the uncertain.
    Silbergleit R; Scott PA
    Acad Emerg Med; 2005 Apr; 12(4):348-51. PubMed ID: 15805327
    [No Abstract]   [Full Text] [Related]  

  • 28. European Cooperative Acute Stroke Study III: support for and questions about a truly emerging therapy.
    Fisher M; Hachinski V
    Stroke; 2009 Jun; 40(6):2262-3. PubMed ID: 19390068
    [No Abstract]   [Full Text] [Related]  

  • 29. Using mismatch on MRI to select thrombolytic responders: an attractive hypothesis awaiting confirmation.
    Davis SM; Donnan GA
    Stroke; 2005 May; 36(5):1106-7. PubMed ID: 15802638
    [No Abstract]   [Full Text] [Related]  

  • 30. Missing the point (estimate)? Confidence intervals for the number needed to treat.
    Barrowman NJ
    CMAJ; 2002 Jun; 166(13):1676-7. PubMed ID: 12126323
    [No Abstract]   [Full Text] [Related]  

  • 31. Third international stroke trial.
    Whiteley W; Lindley R; Wardlaw J; Sandercock P;
    Int J Stroke; 2006 Aug; 1(3):172-6. PubMed ID: 18706043
    [No Abstract]   [Full Text] [Related]  

  • 32. Questions about authorisation of alteplase for ischaemic stroke.
    Shinton R
    Lancet; 2014 Aug; 384(9944):659-60. PubMed ID: 25152265
    [No Abstract]   [Full Text] [Related]  

  • 33. Alteplase for ischaemic stroke--much sooner is much better.
    Saver JL; Levine SR
    Lancet; 2010 May; 375(9727):1667-8. PubMed ID: 20472152
    [No Abstract]   [Full Text] [Related]  

  • 34. Expansion of Intravenous Tissue Plasminogen Activator Eligibility Beyond National Institute of Neurological Disorders and Stroke and European Cooperative Acute Stroke Study III Criteria.
    Marchidann A; Balucani C; Levine SR
    Neurol Clin; 2015 May; 33(2):381-400. PubMed ID: 25907912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acute stroke management.
    Ducharme J; Currie T; Ovens H; Rutledge T; Thompson J
    Can Fam Physician; 2001 Dec; 47():2458. PubMed ID: 11785275
    [No Abstract]   [Full Text] [Related]  

  • 36. IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.
    Reid JM; Gubitz GJ; Phillips SJ
    Neurology; 2006 Nov; 67(9):1724-5; author reply 1724-5. PubMed ID: 17101926
    [No Abstract]   [Full Text] [Related]  

  • 37. Editorial comment--More than one way to lyse a clot.
    Kasner SE
    Stroke; 2004 Apr; 35(4):911-2. PubMed ID: 15044811
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. When is enough enough?
    Donnan GA; Davis SM
    Stroke; 2001 Nov; 32(11):2710-1. PubMed ID: 11692042
    [No Abstract]   [Full Text] [Related]  

  • 40. A panoramic, practice-based view of intravenous alteplase 3-4.5 h after stroke.
    Kasner SE; Levine SR
    Lancet Neurol; 2010 Sep; 9(9):843-5. PubMed ID: 20667791
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.